Onconano Medicine, Inc.
OncoNano
Dallas, United States · Founded 2017 · $50.0M raised
- Headquarters
- Dallas, Texas
- Employees
- 11–50
- Founded
- 2017
- Business Model
- B2B
- Website
- onconano.com
- Total Funding
- $50.0M
- Last Round
- $50.0M Series BJun 2025
- Rounds
- 1
About
OncoNano Medicine is a clinical-stage oncology company developing nanotechnology-enabled cancer therapeutics based on its proprietary ON-BOARD platform, which exploits the acidic tumor microenvironment to maximize intratumoral drug delivery. A spinout of UT Southwestern Medical Center, the Dallas-based company is advancing a pipeline including ONM-501, a dual-acting STING agonist in Phase 1 trials, and pegsitacianine, a fluorescent imaging probe for tumor-guided surgery.
Summary
Onconano Medicine, Inc. is a Biotech company based in Dallas, United States, founded in 2017. It has raised $50.0M in total across 1 round, most recently a $50.0M Series B round in Jun 2025. Investors include Advantech Capital.
Funding History
Jun 2025
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/onconano-medicine-inc"><img src="https://indexed.vc/api/badge/company/onconano-medicine-inc" alt="Onconano Medicine, Inc. on Indexed.vc" width="260" height="76" /></a>